PHIBRO ANIMAL HEALTH CORP Revenue from Contract with Customer, Excluding Assessed Tax in USD from 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Phibro Animal Health Corp quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2020 to Q3 2025.
  • Phibro Animal Health Corp Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2025 was $364M, a 39.7% increase year-over-year.
  • Phibro Animal Health Corp Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending September 30, 2025 was $1.4B, a 33.7% increase year-over-year.
  • Phibro Animal Health Corp annual Revenue from Contract with Customer, Excluding Assessed Tax for 2025 was $1.3B, a 27.4% increase from 2024.
  • Phibro Animal Health Corp annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $1.02B, a 4.07% increase from 2023.
  • Phibro Animal Health Corp annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $978M, a 3.78% increase from 2022.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Growth (%)

PHIBRO ANIMAL HEALTH CORP Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.4B $364M +$103M +39.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $1.3B $379M +$106M +38.6% Apr 1, 2025 Jun 30, 2025 10-K 2025-08-27
Q1 2025 $1.19B $348M +$84.6M +32.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $1.11B $309M +$59.3M +23.7% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-05
Q3 2024 $1.05B $260M +$29.1M +12.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $1.02B $273M +$18.1M +7.1% Apr 1, 2024 Jun 30, 2024 10-K 2025-08-27
Q1 2024 $1B $263M +$17.6M +7.14% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 $982M $250M +$5.3M +2.17% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-05
Q3 2023 $977M $231M -$1.17M -0.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $978M $255M -$216K -0.09% Apr 1, 2023 Jun 30, 2023 10-K 2025-08-27
Q1 2023 $978M $246M +$6.05M +2.53% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $972M $245M +$11.9M +5.13% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q3 2022 $960M $233M +$17.9M +8.32% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $942M $255M Apr 1, 2022 Jun 30, 2022 10-K 2024-08-28
Q1 2022 $240M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $233M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 $215M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09

PHIBRO ANIMAL HEALTH CORP Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $1.3B +$279M +27.4% Jul 1, 2024 Jun 30, 2025 10-K 2025-08-27
2024 $1.02B +$39.8M +4.07% Jul 1, 2023 Jun 30, 2024 10-K 2025-08-27
2023 $978M +$35.6M +3.78% Jul 1, 2022 Jun 30, 2023 10-K 2025-08-27
2022 $942M +$109M +13.1% Jul 1, 2021 Jun 30, 2022 10-K 2024-08-28
2021 $833M +$33M +4.12% Jul 1, 2020 Jun 30, 2021 10-K 2023-08-30
2020 $800M Jul 1, 2019 Jun 30, 2020 10-K 2022-08-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.